Atherosclerosis
Conditions
Keywords
Hand held Ultrasound, Office practice, Atherosclerosis prevention, Ultrasound training
Brief summary
The purposes of this study are to determine: 1. Inter-site variability in CIMT image measurement using SonoCalcTM. 2. If non-sonographer health care professionals working in an office practice setting can be trained to follow a carotid scanning protocol that permits (a) accurate measurement of CIMT and (b) determination of plaque presence. 3. If (a) CIMT measurements and (b) determination of plaque presence by non-sonographer health care professionals are bioequivalent to those made by a core laboratory. 4. If CIMT measurements and plaque assessment performed in office practices lead to meaningful changes in patient and physician behavior related to cardiovascular disease prevention.
Detailed description
Phase IV Type (observational vs. interventional) Observational Currently recruiting or not? NO Randomized? (or not) No Blinded? (single, double, or open) Primary outcome(s) Bioequivalency of carotid IMT measurements. Secondary outcome(s) Variability in carotid IMT measurements Intention to behavior change in patients Effects of carotid IMT on physician management Type of Intervention (e.g., drug; device; behavioral) Device Name of Intervention Handheld ultrasound measurement of carotid IMT
Interventions
PROCEDURECarotid Ultrasound performed in office practice
Sponsors
University of Wisconsin, Madison
Study design
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
45 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
* Males over 45 years and females over 55 years of age with at least one additional risk factor for coronary artery disease. * Females 45-54 years old may be enrolled if they have a family history of CHD (myocardial infarction, coronary artery bypass graft surgery, angioplasty, sudden cardiac death) in a male first degree relative \<55 or a female first degree relative \<65 years old AND at least one additional risk factor for coronary artery disease.
Exclusion criteria
* Age \>70 years * Subjects taking cholesterol-lowering medications * Active liver disease * Active thyroid disease * Uncontrolled hypertension * Chronic kidney disease * History of coronary artery disease * History of cerebrovascular disease * History of peripheral arterial disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bioequivalency of carotid IMT measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| Variability in carotid IMT measurements | — |
| Intention to behavior change in patients | — |
| Effects of carotid IMT on physician management | — |
Countries
United States
Outcome results
None listed